Andmed seisuga: 04.07.2024 06:11 (GMT+3)
TALLINNA FARMAATSIATEHASE AS
INCOME STATEMENT
01.07-30.09.99
Unaudited
in EEK Group Parent
Q3 1999 Q3 1998 Q3 1999 Q3 1998
REVENUE
NET SALES 15,041,614 14,564,120 15,041,614 14,564,120
CHANGE IN INVENTORIES -2,262,020 -2,805,789 -2,262,020 -2,805,789
OTHER REVENUE 721,952 -257,551 721,952 -257,551
TOTAL REVENUE 13,501,186 11,500,780 13,501,186 11,500,780
EXPENSES
MATERIALS, CONSUMABLES AND SUPPLIES -5,768,223 -6,005,305 -5,768,223 -6,000,761
OTHER OPERATING EXPENSES -1,382,880 -5,363,076 -1,382,880 -5,324,759
PERSONNEL EXPENSES -3,780,363 -5,945,930 -3,780,363 -5,717,587
DEPRECIATION -1,432,094 -1,888,461 -1,432,094 -1,846,394
OTHER EXPENSES -1,531,915 -10,056,864 -1,531,915 -10,056,864
TOTAL EXPENSES (13,895,475) -29,259,636 -13,895,475 -28,946,365
OPERATING PROFIT (-LOSS) -394,289 -17,758,856 -394,289 -17,445,585
INCOME/COST OF EQUITY HOLDING 3,560,061 - 3,560,061 -
OTHER FINANCIAL INCOME 69,820 194,179 69,820 119,908
AMORTIZATION OF GOODWILL -378,334 -782,751 -378,334 -782,751
OTHER FINANCIAL EXPENSES -1,269,338 -2,194,044 -1,269,339 -2,092,574
TOTAL 1,982,208 -2,782,616 1,982,208 -2,755,417
PROFIT (-LOSS) BEFORE 1,587,919 -20,541,472 1,587,919 -20,201,002
INCOME TAX
INCOME TAX 0 0 0 0
Incl. DEFERRED INCOME TAX
PROFIT AFTER INCOME TAX 1,587,919 -20,541,472 1,587,919 -20,201,002
NET PROFIT (-LOSS) FOR Q3 1,587,919 -20,541,472 1,587,919 -20,201,002
Earnings per share 1,27 -5,45
Sisukaart